Currently also: Chief Informatics and Technology Officer (CITO) at Pangea Botanica, London/UK and Berlin/Germany
Previous positions:
Director Digital Chemistry at NUVISAN Berlin
Associate Director Computational ADME and Safety (Clinical Pharmacology & Safety Sciences/Data Science and Artificial Intelligence - CPSS/DSAI) at AstraZeneca Cambridge
Co-founder of Healx Ltd.
Co-founder of PharmEnable Ltd.
- Committed to developing new life science data analysis methods (AI/ML/data science) and their application, primarily related to chemical biology, drug discovery and in silico toxicology
- Expertise comprises data ranging from chemical structure and gene expression data to phenotypic readouts and preclinical information, applied to both efficacy- and safety/tox-related questions
- Collaborating with academic research groups, as well as pharmaceutical, chemical, and consumer goods companies (Eli Lilly, AstraZeneca, GSK, BASF, Johnson&Johnson/Janssen, Unilever, ...)
- Co-founder/founding CTO and current SAB member of Healx Ltd. (data-driven drug repurposing for rare diseases, and beyond); co-founder of PharmEnable Ltd.; SAB member of Lhasa Ltd. (toxicology and metabolism prediction) and Cresset Ltd.
- Coordinator of the Computational & In Silico Toxicology Specialty Section of the British Toxicology Society (BTS)
- Steering Committee Member of the Cambridge Alliance on Medicines Safety (CAMS)
- Currently leading a group of ca. 15 PhD students, postdocs, project students and visitors at the Centre for Molecular Informatics at the University of Cambridge, https://www-cmi.ch.cam.ac.uk/centre-molecular-informatics
Publications
Harvesting Chemical Information from the Internet Using a Distributed Approach: ChemXtreme
– J Chem Inf Model
(2006)
46,
452
(doi: 10.1021/ci050329+)
Characterizing bitterness: identification of key structural features and development of a classification model.
– J Chem Inf Model
(2006)
46,
569
(doi: 10.1021/ci0504418)
Diversity Oriented Synthesis: A Challenge for Synthetic Chemists
– Ernst Schering Research Foundation workshop
(2006)
58,
47
(doi: 10.1007/978-3-540-37635-4_4)
Molecular similarity searching using COSMO screening charges (COSMO/3PP)
– Lecture Notes in Computer Science
(2005)
3695 LNBI,
175
(doi: 10.1007/11560500_16)
Screening for dihydrofolate reductase inhibitors using MOLPRINT 2D, a fast fragment-based method employing the naïve Bayesian classifier: limitations of the descriptor and the importance of balanced chemistry in training and test sets.
– Journal of biomolecular screening
(2005)
10,
658
(doi: 10.1177/1087057105281048)
Discussion of measures of enrichment in virtual screening: Comparing the information content of descriptors with increasing levels of sophistication
– JOURNAL OF CHEMICAL INFORMATION AND MODELING
(2005)
45,
1369
(doi: 10.1021/ci0500177)
A Discussion of Measures of Enrichment in Virtual Screening: Comparing the Information Content of Descriptors with Increasing Levels of Sophistication
– Journal of chemical information and modeling
(2005)
45,
1369
(doi: 10.1021/ci0500177)
Assessment of structural diversity in combinatorial synthesis
– Curr Opin Chem Biol
(2005)
9,
304
(doi: 10.1016/j.cbpa.2005.03.004)
General melting point prediction based on a diverse compound data set and artificial neural networks
– J Chem Inf Model
(2005)
45,
581
(doi: 10.1021/ci0500132)
Encoding and decoding graphical chemical structures as two-dimensional (PDF417) barcodes.
– Journal of chemical information and modeling
(2005)
45,
572
(doi: 10.1021/ci049758i)
- <
- 41 of 42